Sight Sciences, Inc.
SGHT
$3.55
$0.133.80%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 78.11M | 79.87M | 79.54M | 79.40M | 81.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 78.11M | 79.87M | 79.54M | 79.40M | 81.50M |
| Cost of Revenue | 11.20M | 11.58M | 11.84M | 11.27M | 11.63M |
| Gross Profit | 66.91M | 68.29M | 67.70M | 68.12M | 69.87M |
| SG&A Expenses | 98.79M | 100.83M | 100.29M | 103.40M | 106.78M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 127.78M | 130.40M | 129.26M | 131.29M | 135.93M |
| Operating Income | -49.67M | -50.53M | -49.71M | -51.90M | -54.43M |
| Income Before Tax | -49.14M | -51.27M | -50.14M | -52.20M | -54.63M |
| Income Tax Expenses | 260.00K | 236.00K | 208.00K | 120.00K | 113.00K |
| Earnings from Continuing Operations | -49.40 | -51.51 | -50.35 | -52.32 | -54.75 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -49.40M | -51.51M | -50.35M | -52.32M | -54.75M |
| EBIT | -49.67M | -50.53M | -49.71M | -51.90M | -54.43M |
| EBITDA | -49.00M | -49.82M | -49.02M | -51.20M | -53.77M |
| EPS Basic | -0.98 | -1.03 | -1.01 | -1.06 | -1.12 |
| Normalized Basic EPS | -0.61 | -0.62 | -0.61 | -0.64 | -0.67 |
| EPS Diluted | -0.98 | -1.03 | -1.01 | -1.06 | -1.12 |
| Normalized Diluted EPS | -0.61 | -0.62 | -0.61 | -0.64 | -0.67 |
| Average Basic Shares Outstanding | 202.33M | 200.53M | 198.63M | 196.96M | 195.59M |
| Average Diluted Shares Outstanding | 202.33M | 200.53M | 198.63M | 196.96M | 195.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |